These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36273821)

  • 1. Quantitative Model Analysis and Simulation of Pharmacokinetics and
    Goto A; Yamamoto S; Igari T; Matsumoto SI; Chisaki I; Iida K; Nakayama M; Oda A; Kakoi Y; Uchida A; Miyata K; Nishikawa M; Nagata T; Kusuhara H; Yokota T; Hirabayashi H
    J Pharmacol Exp Ther; 2023 Jan; 384(1):197-204. PubMed ID: 36273821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides.
    Nishi R; Ohyagi M; Nagata T; Mabuchi Y; Yokota T
    Mol Ther; 2022 Jun; 30(6):2210-2223. PubMed ID: 35189344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage.
    Li F; Ichinose K; Ishibashi S; Yamamoto S; Iwasawa E; Suzuki M; Yoshida-Tanaka K; Yoshioka K; Nagata T; Hirabayashi H; Mogushi K; Yokota T
    Mol Ther; 2023 Apr; 31(4):1106-1122. PubMed ID: 36694463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve.
    Kaburagi H; Nagata T; Enomoto M; Hirai T; Ohyagi M; Ihara K; Yoshida-Tanaka K; Ebihara S; Asada K; Yokoyama H; Okawa A; Yokota T
    Mol Ther Nucleic Acids; 2022 Jun; 28():910-919. PubMed ID: 35694210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.
    Nishina K; Piao W; Yoshida-Tanaka K; Sujino Y; Nishina T; Yamamoto T; Nitta K; Yoshioka K; Kuwahara H; Yasuhara H; Baba T; Ono F; Miyata K; Miyake K; Seth PP; Low A; Yoshida M; Bennett CF; Kataoka K; Mizusawa H; Obika S; Yokota T
    Nat Commun; 2015 Aug; 6():7969. PubMed ID: 26258894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
    Asada K; Sakaue F; Nagata T; Zhang JC; Yoshida-Tanaka K; Abe A; Nawa M; Nishina K; Yokota T
    Nucleic Acids Res; 2021 May; 49(9):4864-4876. PubMed ID: 33928345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
    Nagata T; Dwyer CA; Yoshida-Tanaka K; Ihara K; Ohyagi M; Kaburagi H; Miyata H; Ebihara S; Yoshioka K; Ishii T; Miyata K; Miyata K; Powers B; Igari T; Yamamoto S; Arimura N; Hirabayashi H; Uchihara T; Hara RI; Wada T; Bennett CF; Seth PP; Rigo F; Yokota T
    Nat Biotechnol; 2021 Dec; 39(12):1529-1536. PubMed ID: 34385691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking.
    Ono D; Asada K; Yui D; Sakaue F; Yoshioka K; Nagata T; Yokota T
    Mol Ther Nucleic Acids; 2021 Mar; 23():1360-1370. PubMed ID: 33738132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo.
    Kuwahara H; Song J; Shimoura T; Yoshida-Tanaka K; Mizuno T; Mochizuki T; Zeniya S; Li F; Nishina K; Nagata T; Ito S; Kusuhara H; Yokota T
    Sci Rep; 2018 Mar; 8(1):4377. PubMed ID: 29531265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo.
    Ohyagi M; Nagata T; Ihara K; Yoshida-Tanaka K; Nishi R; Miyata H; Abe A; Mabuchi Y; Akazawa C; Yokota T
    Nat Commun; 2021 Dec; 12(1):7344. PubMed ID: 34937876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo.
    Asami Y; Nagata T; Yoshioka K; Kunieda T; Yoshida-Tanaka K; Bennett CF; Seth PP; Yokota T
    Mol Ther; 2021 Feb; 29(2):838-847. PubMed ID: 33290725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of antisense oligonucleotide in mice.
    Shimizu R; Kitade M; Kobayashi T; Hori S; Watanabe A
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):67-77. PubMed ID: 25376372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Long Noncoding RNA MALAT1 in Diabetic Polyneuropathy and the Impact of Its Silencing in the Dorsal Root Ganglion by a DNA/RNA Heteroduplex Oligonucleotide.
    Miyashita A; Kobayashi M; Ishibashi S; Nagata T; Chandrasekhar A; Zochodne DW; Yokota T
    Diabetes; 2022 Jun; 71(6):1299-1312. PubMed ID: 35276003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
    Yoshioka K; Kunieda T; Asami Y; Guo H; Miyata H; Yoshida-Tanaka K; Sujino Y; Piao W; Kuwahara H; Nishina K; Hara RI; Nagata T; Wada T; Obika S; Yokota T
    Nucleic Acids Res; 2019 Aug; 47(14):7321-7332. PubMed ID: 31214713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of thrombocytopenia caused by cholesterol-conjugated antisense oligonucleotides.
    Harada K; Furukawa H; Kohara H; Nishimura K; Komori H; Okai Y; Arai Y; Yamamoto Y; Yamamoto K; Imanishi A; Shinozawa T
    Toxicol In Vitro; 2023 Jun; 89():105569. PubMed ID: 36801361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells.
    Sousa de Almeida M; Rothen-Rutishauser B; Mayer M; Taskova M
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Silencing Activity and Hepatic Accumulation of Antisense Oligonucleotides Bearing Cholesterol-Conjugated Thiono Triester at the Gap Region.
    Nakajima M; Kasuya T; Yokota S; Onishi R; Ikehara T; Kugimiya A; Watanabe A
    Nucleic Acid Ther; 2017 Aug; 27(4):232-237. PubMed ID: 28418770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery system of therapeutic oligonucleotides.
    Asami Y; Yoshioka K; Nishina K; Nagata T; Yokota T
    Drug Discov Ther; 2016; 10(5):256-262. PubMed ID: 27890899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice.
    Suzuki M; Ishibashi S; Iwasawa E; Oguma T; Saito Y; Li F; Otsu S; Ichinose K; Yoshioka K; Nagata T; Yokota T
    Sci Rep; 2021 Jul; 11(1):14237. PubMed ID: 34244578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.